DSE : UNILEVERCL
Unilever Consumer Care Limited — Key statistics
Pharmaceutical Preparations · Bangladesh
Last price 1952.9 BDT (At close: Oct 29, 2026) · Market cap 37.64B
Latest research: Unilever Consumer Care valuation report: fair value BDT 144–351 (Oct 2026) · Fair value BDT 144-351 a share: Horlicks volume fell 14% in H1 2026 and gross margin is 31%
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 37.64B |
| Enterprise Value | 34.91B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Apr 7, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 19.27M |
| Shares Outstanding | 19.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.87% |
| Float | 3.47M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 71.08 |
| Forward PE | n/a |
| PS Ratio | 11.44 |
| PB Ratio | 20.97 |
| P/TBV Ratio | 20.97 |
| P/FCF Ratio | 63.25 |
| P/OCF Ratio | 58.59 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 65.92 |
| EV / Sales | 10.61 |
| EV / EBITDA | 74.84 |
| EV / EBIT | 83.76 |
| EV / FCF | 58.67 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.89 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.15 |
| Interest Coverage | 31.61 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 27.40% |
| Return on Assets (ROA) | 7.16% |
| Return on Invested Capital (ROIC) | 12.87% |
| Return on Capital Employed (ROCE) | 21.97% |
| Weighted Average Cost of Capital (WACC) | 4.87% |
| Revenue Per Employee | 96.78M |
| Profits Per Employee | 15.58M |
| Employee Count | 34 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 5.79 |
Taxes
| Measure | Value |
|---|
| Income Tax | 156.77M |
| Effective Tax Rate | 22.84% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -18.60% |
| 50-Day Moving Average | 1,989.89 |
| 200-Day Moving Average | 2,079.41 |
| Relative Strength Index (RSI) | 36.22 |
| Average Volume (20 Days) | 200 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.29B |
| Gross Profit | 1.06B |
| Operating Income | 416.82M |
| Pretax Income | 686.41M |
| Net Income | 529.64M |
| EBITDA | 440.96M |
| EBIT | 416.82M |
| Earnings Per Share (EPS) | 27.47 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.81B |
| Total Debt | 87.41M |
| Net Cash | 2.73B |
| Net Cash Per Share | 141.49 |
| Equity (Book Value) | 1.80B |
| Book Value Per Share | 93.11 |
| Working Capital | 1.54B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 642.46M |
| Capital Expenditures | -47.37M |
| Depreciation & Amortization | 10.88M |
| Net Borrowing | -26.62M |
| Free Cash Flow | 595.09M |
| FCF Per Share | 30.87 |
Margins
| Measure | Value |
|---|
| Gross Margin | 32.20% |
| Operating Margin | 12.67% |
| Pretax Margin | 20.86% |
| Profit Margin | 16.10% |
| EBITDA Margin | 13.40% |
| EBIT Margin | 12.67% |
| FCF Margin | 17.39% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 42.00 |
| Dividend Yield | 2.15% |
| Dividend Growth (YoY) | -19.23% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 152.75% |
| FCF Payout Ratio | 141.28% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.15% |
| Earnings Yield | 1.41% |
| FCF Yield | 1.58% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 4, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |